Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).
Franziska C TrudzinskiRudolf A JörresPeter AlterHenrik WatzClaus F VogelmeierHans-Ulrich KauczorSubasini ThangamaniManuel DebicTobias WelteJürgen BehrKathrin KahnertRobert BalsChristian HerrClaus Peter HeußelJürgen BiedererOyunbileg von StackelbergSebastian FähndrichEmiel F M WoutersBenjamin WaschkiKlaus F RabeFelix J F HerthViktoria Palmnull nullPublished in: Respiratory research (2024)
ClinicalTrials.gov NCT01245933, Date of registration: 18 November 2010.